Rachel Jacobson
@Raymond James & Associates
Latest period2024 - Q3ReportedManaged Assets$164.079BTotal holdings3937
Assets growth rate7.75%Assets growth rate (2-Q avg)5.5%Continuous growth in asset value4 quarters
Portfolio positions
This chart displays the top 10 holdings in Raymond James & Associates's 2024 - Q3 portfolio, based on their 13F SEC filing, out of a total of 3937 positions.
Assets under management
The assets under management (AUM) of Raymond James & Associates over the past 10 years (40 quarters) show continuous growth in total asset value over the last 4 quarters. As of the latest 13F SEC filing for 2024 - Q3, they manage 164.079B in assets, with a quarterly growth rate of 7.75% and a 2-quarter average growth rate of 5.5%. The portfolio is managed by Rachel Jacobson, and others.
Portfolio holdings
Investment | Portfolio % | Reported Value | Recent Activity |
---|---|---|---|
RXSTRxsight Inc
| 0% | $3.549M 58,988 shares@ $60.18 avg price | Exited |
ATRIAtrion Corp
| 0% | $3.2M 7,072 shares@ $452.43 avg price | Exited |
PXJInvesco Exchange Traded Fd T
| 0% | $2.679M 83,809 shares@ $31.97 avg price | Exited |
DHDefinitive Healthcare Corp
| 0% | $2.658M 486,819 shares@ $5.46 avg price | Exited |
CCRNCross Ctry Healthcare Inc
| 0% | $2.288M 165,324 shares@ $13.84 avg price | Exited |
INDBIndependent Bk Corp Mass
| 0% | $2.078M 40,977 shares@ $50.72 avg price | Exited |
SHAGWisdomtree Tr
| 0% | $1.999M 42,591 shares@ $46.95 avg price | Exited |
FSDFirst Tr High Income Long
| 0% | $1.933M 156,646 shares@ $12.34 avg price | Exited |
UUPInvesco Db Us Dlr Index Tr
| 0% | $1.882M 64,614 shares@ $29.14 avg price | Exited |
GTHXG1 Therapeutics Inc
| 0% | $1.819M 797,677 shares@ $2.29 avg price | Exited |